TNFRSF12A and lobular neoplasia: The TWEAK/Fn14 signaling pathway has been identified as a potential therapeutic target for LN because of its role in promoting inflammation, angiogenesis, cell proliferation, and fibrosis: all biological processes that contribute to LN pathology [reviewed in Ref.